Source: Eur Respir J 2016; 47: 1198-1207
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vis Roeland, Malviya Gaurav, Signore Alberto, Grutters Jan C., Meek Bob, van de Garde Ewoudt M.W., Keijsers Ruth G.M.. 99mTc-anti-TNF-alpha antibody for the imaging of disease activity in pulmonary sarcoidosis. Eur Respir J 2016; 47: 1198-1207

Member's Comments

No comment yet.

Related content which might interest you: Antielastin antibodies in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity. Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema Source: Eur Respir J 2009; 33: 219-221 Year: 2009 Detection of various autoantibodies in patients with pulmonary sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Pulmonary manifestations of immunoglobulin G4-related sclerosing disease Source: Eur Respir J 2012; 39: 180-186 Year: 2012 Pulmonary manifestations of immunoglobulin G4-related sclerosing disease Source: Eur Respir J 2011; 39: 180-186 Year: 2012 The Dutch hypothesis, implications for treatment of chronic obstructive pulmonary disease and asthma in a biomarker, monoclonal antibody world. Experience with IgE and omalizumab in a small pulmonary practice Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Functional imaging of disease activity in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 266s Year: 2002 Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension Source: Eur Respir J 2006 Oct 01;28(4):799-807 Year: 2006 Detection of antibody response against influenza vaccine in patients with chronic obstructive pulmonary disease (COPD) by quantitative ELISA and evalution of clinical findings Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 Circulating auto antibodies in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 CT imaging manifestations of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 847s Year: 2006 CT imaging manifestations of pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 428s Year: 2004 CT imaging manifestations of pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 248s Year: 2003 Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan) Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Change of lung function in severe eosinophilic asthma undergoing treatment with anti-interleukin-5 monoclonal antibody Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018